Zi-ying Zhou
Chinese Academy Of Medical Sciences & Peking Union Medical College
Beijing, 100050, China
Beijing, 100050, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Structure-Based Virtual Screening for KHK-A Inhibitors with Anti-Hepatocellular Carcinoma Activity.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: October 05, 2025
Progress in anti-ageing drug research for age-related diseases: A review.
Journal: Ageing research reviews
Published: September 22, 2025
Substituted indole derivatives as UNC-51-like kinase 1 inhibitors: Design, synthesis and anti-hepatocellular carcinoma activity.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: April 26, 2024
Design and synthesis of dabigatran etexilate derivatives with inhibiting thrombin activity for hepatocellular carcinoma treatment.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: October 16, 2023
Advances in inhibitors of potential tumor target FOXM1.
Journal: Future medicinal chemistry
Published: May 25, 2023
Efficacy, Mechanism, and Structure-Activity Relationship of 6-Methoxy Benzofuran Derivatives as a Useful Tool for Senile Osteoporosis.
Journal: Journal of medicinal chemistry
Published: January 20, 2023
Synthesis and anti-ovarian cancer effects of benzimidazole-2-substituted pyridine and phenyl propenone derivatives.
Journal: Future medicinal chemistry
Published: November 14, 2022
Structure-based virtual screening identified novel FOXM1 inhibitors as the lead compounds for ovarian cancer.
Journal: Frontiers in chemistry
Published: September 30, 2022
Structure-based virtual screening towards the discovery of novel FOXM1 inhibitors.
Journal: Future medicinal chemistry
Published: November 23, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026